The latest front in the increasingly strained relationship between the pharma industry and the medical profession has just opened up. Bad Guidelines, an initiative led by doctors and medical students points the finger at this

Neil Pakenham-Walsh and Molly Land discuss their newly published white paper, Access to Health Information Under International Human Rights Law. People are dying for lack of knowledge Access to information is critical for the protection

Ruby Singhrao reports from last month’s TEDx San Franicsco conference, dedicated to advances in global health. On November 10th 2012, the University of California San Francisco (UCSF) hosted a TEDx conference on global health. The

Faraz Ahmed reports from last month’s Public Health Science conference dedicated to new research in public health at the Royal Society of Medicine in London, United Kingdom. As a public health researcher, I am often

Carl Heneghan, Director of the University of Oxford’s Centre of Evidence-Based Medicine, discusses recent developments in access to clinical-trial data. The Pharmaceutical industry and drug regulators treat clinical data, submitted at the time of regulation,

The National Committee of PharmAware, a UK-based student organisation, review ‘Bad Pharma’ by Ben Goldacre. Medical students are taught to make decisions for patients on the basis of the best available evidence. What they are

Anne Radl from The Humanitarian Centre discusses ‘Partnerships for global health: pathways to progress’ a new report reflecting on the centre’s focus on global health over the last year. “Everyone has something to teach and

Four new articles published this week in PLOS Medicine: Helen Colhoun and colleagues report findings from a Scottish registry linkage study of contemporary risks for cardiovascular events and all-cause mortality among individuals diagnosed with type

Four new articles published this week in PLOS Medicine: Helen Colhoun and colleagues report findings from a Scottish registry linkage study of contemporary risks for cardiovascular events and all-cause mortality among individuals diagnosed with type